Couples Therapy: Challenges In Companion Dx-Biopharma Relationships Noted By VC
Executive Summary
Companion diagnostic firms facing skeptical partners in big pharma need to focus on ways of establishing the value of their test to payers and patients, Third Rock Ventures’ Mark Levin advised the Personalized Medicine Coalition.